Becton Dickinson and Company (BDX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Becton Dickinson and Company, updated every trading day.
Health Care · Medical/Dental Instruments
Price
$195.16
+0.07% today
Market cap
$53.1B
Overall quality
52/100
Kronos AI 30-day
−14.6%
0 of 8 simulated paths end higher
Becton Dickinson and Company (BDX) is a Health Care company in Medical/Dental Instruments, worth $53.1B. It trades at $195.16, up 0.07% today, at 32.3 times earnings. Its overall quality score is 52 out of 100, ranked against the whole US market. 10 analysts' average target of $191.80 implies −1.7% from today's price. Kronos AI's 30-day forecast is −14.6% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $191.80 |
| Low – high | $165.00 – $210.00 |
| Analysts | 10 |
| Upside to average | −1.7% |
Kronos AI 30-day forecast
| Expected close | $166.59 (−14.6%) |
| Likely range | −18.7% … −10.5% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
| Profitability | 64 |
| Solvency | 44 |
| Growth | 49 |
| Overall | 52 |
| P/E | 32.3 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Medical/Dental Instruments
For information only, not investment advice. Prices updated: 2026-10-29.